Modiodal (Modafinil)

Modafinil primarily blocks the reuptake of dopamine, raising its concentration in the brain. It also influences orexin, histamine, norepinephrine, and serotonin systems, which together enhance cortical activation and reduce the propensity for sleep without causing the rapid heart‑rate spikes typical of classic stimulants.

The specific dose of Modiodal is determined by the prescribing clinician based on the patient’s condition, response, and overall health profile. Healthcare professionals follow established guidelines and adjust the regimen as needed, ensuring individualized and safe therapy.

Safety data for modafinil in pregnancy and lactation are limited. The prescriber should weigh potential benefits against unknown risks and discuss alternative options when possible. Women who are pregnant, planning pregnancy, or breastfeeding should consult their healthcare provider before using Modiodal.

To request Modiodal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Modiodal (modafinil) differs from traditional stimulants such as methylphenidate by offering a lower risk of cardiovascular stimulation and a longer duration of action. Compared with armodafinil, its racemic counterpart, Modiodal provides similar efficacy but may have a slightly different side‑effect profile, allowing clinicians to choose based on patient tolerance.

Modiodal should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, heat, and direct sunlight. Do not store in bathrooms or near kitchen appliances that generate excess humidity.

Modiodal is taken orally, usually with a glass of water. The tablet is swallowed whole and not intended to be chewed, crushed, or split unless specifically instructed by a healthcare professional. It is generally taken once daily in the morning to align with the patient’s waking schedule.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, psychiatric events like hallucinations or mania, and rare cardiac arrhythmias. Patients should seek immediate medical attention if they notice rash, mood changes, chest pain, or irregular heartbeat while using Modiodal.

Modiodal is contraindicated in individuals with known hypersensitivity to modafinil or any of its excipients. It should also be avoided in patients taking monoamine oxidase inhibitors within 14 days, those with uncontrolled hypertension, and persons with a history of severe psychiatric disorders unless closely monitored.